Integra LifeSciences Holdings Corporation IART
14.65 USD +1.02 (+7.48%)
Nov 4, 2026, 10:09 AM EST
13.84 Day range 15.15
8.70 52-week range 20.49
- YTD
- +17.95%
- 1 year
- +29.65%
Analyst view
Consensus: hold
Hold
Price target (mean) 15.67 +6.9% upside
Now 14.65
- Target (low)
- 13.00
- Target (mean)
- 15.67
- Target (high)
- 23.00
Ratings (0m) 12 3 buy · 7 hold · 2 sell
- Strong buy1
- Buy2
- Hold7
- Sell0
- Strong sell2
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.64335 | 0.62 – 0.67 | 0.83 | -22.5% | 422.37M | -2.9% | 11 |
| Next quarter | 0.49353 | 0.41 – 0.60 | 0.54 | -8.6% | 388.16M | -1.0% | 8 |
| Current year | 2.33 | 2.31 – 2.35 | 2.23 | +4.7% | 1.64B | +0.5% | 11 |
| Next year | 2.39 | 2.30 – 2.67 | 2.33 | +2.3% | 1.67B | +1.9% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 26, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 22, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 22, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 22, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 22, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 22, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Oct 14, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 5, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 28, 2026 | UBS | Initiated | — | Neutral |
| Jul 16, 2026 | Truist Securities | Maintained | Hold | Hold |
| Jul 9, 2026 | BMO Capital | Initiated | — | Market Perform |
| Jul 8, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 28, 2026 | Citigroup | Upgrade | Sell | Neutral |
| May 6, 2026 | Citigroup | Maintained | Sell | Sell |
| May 6, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 15, 2026 | Truist Securities | Maintained | Hold | Hold |
| Apr 15, 2026 | Argus Research | Downgrade | Buy | Hold |
| Mar 11, 2026 | Citigroup | Maintained | Sell | Sell |
| Feb 27, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 3, 2025 | Truist Securities | Reiterated | Hold | Hold |
| Oct 31, 2025 | Citigroup | Maintained | Sell | Sell |
| Oct 31, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Oct 15, 2025 | Truist Securities | Maintained | Hold | Hold |
| Oct 7, 2025 | Citigroup | Maintained | Sell | Sell |
| May 9, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| May 6, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| May 6, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
